Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--50件: 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
2Cyclophosphamide (CYC)1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 49, 221 💬
3ECULIZUMAB1件: Eculizumab1件: Eculizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬8件: 11, 13, 14, 61, 62, 109, 221, 223 💬
4EFALIZUMAB1件: Efalizumab1件: Efalizumab 💬 1件: ITGAL 💬 14件: Cell adhesion molecule (CAM) interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, IgSF CAM signaling, Integrin signaling, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬10件: 11, 13, 37, 46, 48, 53, 61, 95, 96, 221 💬
5Glucocorticoids----13件: 35, 40, 41, 43, 44, 49, 60, 61, 62, 75, 96, 221, 300 💬
6HMED-IdeS----2件: 64, 221 💬
7Imlifidase1件: Imlifidase1件: Imlifidase 💬 --4件: 43, 44, 113, 221 💬
8KJ103 for Injection----1件: 221 💬
9Plasma exchange (PE)----6件: 11, 13, 64, 66, 221, 223 💬
10Plasma exchange (PLEX)----1件: 221 💬
11Raptiva 100 mg/ml powder and solvent for solution for injection----9件: 11, 13, 46, 48, 53, 61, 95, 96, 221 💬